Erythropoiesis and Its Regulation
On this page
Direct answer
The kidney, not the bone marrow, is the body's oxygen sensor: about 90% of erythropoietin comes from peritubular interstitial cells of the renal cortex, with the liver contributing the rest. When tissue hypoxia stabilises HIF-1 alpha, the EPO gene is switched on, circulating erythropoietin rises within hours, and it rescues erythroid progenitors (CFU-E) from apoptosis — reticulocytes appear in blood within one to two days and red cell output can rise several-fold. Everything else in erythropoiesis — site, raw materials, maturation sequence — serves this single feedback loop between oxygen supply and red cell mass.
What you must remember
- Erythropoietin is a glycoprotein; about 90% is produced by peritubular interstitial cells of the renal cortex, 10% by the liver.
- Oxygen sensing works through HIF-1 alpha: normally hydroxylated by an oxygen-dependent enzyme and degraded via the VHL pathway, it accumulates in hypoxia and drives EPO transcription.
- Sites through life — yolk sac (first trimester), liver and spleen (mid-fetal, hepatic phase), bone marrow from about the fifth month; after puberty active marrow contracts to the axial skeleton: vertebrae, sternum, ribs, ilium, skull and proximal femur and humerus.
- Maturation sequence from proerythroblast through basophilic and polychromatophilic and orthochromatic normoblasts to reticulocyte, then erythrocyte; roughly 5–7 days.
- The body makes about 2.4 million red cells every second; red cell lifespan is 120 days, and 1 g of haemoglobin degraded yields about 35 mg of bilirubin.
- Requirements: iron and protoporphyrin for haem, protein for globin, vitamin B12 and folate for DNA synthesis (deficiency arrests nuclear maturation — megaloblastic anaemia).
- Reticulocytes are 0.5–2.5% of red cells — the live index of marrow response; "shift reticulocytes" are marrow-retained young cells released early by EPO stress.
- Chronic kidney disease anaemia is EPO-deficiency anaemia; recombinant erythropoietin targets a haemoglobin of about 10–12 g/dL, since full correction raises cardiovascular thrombotic risk.
From hypoxia to reticulocyte in five days
Climb to Leh at 3,500 metres or lose 500 mL of blood by donation, and the same cascade runs. Within hours, renal cortical interstitial cells register falling oxygen delivery; HIF-1 alpha escapes degradation and EPO mRNA appears; serum EPO can rise several-fold within 24 hours. EPO acts at the CFU-E stage, activating anti-apoptotic genes so progenitors that would have died instead mature; the marrow transit time shortens and larger, younger reticulocytes are pushed out — reticulocytosis by day 2–3, visible on a methylene-blue smear as bluish polychromatophilic cells.
The marrow can multiply output severalfold, but only if materials arrive: iron from recycled senescent cells (macrophage haemoglobin turnover supplies about 20–25 mg of iron daily against the 1–2 mg absorbed from diet), folate and B12 for the nuclear divisions that shrink the normoblast nucleus. Failure modes localise neatly in the pathway — renal failure starves it of EPO, iron deficiency of haem, B12 deficiency of DNA, and marrow aplasia of the progenitors themselves, each producing a recognisable reticulocyte count and blood film.
Viva angles on red cell production
Examiners probe three junctions. "Why is the sternum chosen for marrow aspiration?" — because in the adult, red marrow persists in the sternum, iliac crest and vertebral bodies; the iliac crest is the usual Indian practice site. "Why does anaemia develop in chronic kidney disease even though the marrow is normal?" — the sensor, not the factory, has failed; the answer also explains why uraemic patients respond to epoetin. "Why is EPO also a doping agent?" — athletes exploit the same loop to raise haematocrit and oxygen-carrying capacity, at the cost of hyperviscosity and thrombosis. One integrative favourite: "In emphysema, EPO is high yet the patient is not polycythaemic for long" — chronic inflammation raises hepcidin and locks iron away, blunting the erythroid response.
Frequently asked questions
Where is erythropoietin produced, and what stimulates its release?
About 90% comes from peritubular interstitial cells of the renal cortex and 10% from the liver; tissue hypoxia, via stabilised HIF-1 alpha, is the stimulus.
What are the sites of erythropoiesis at different ages?
Yolk sac in the first trimester, liver and spleen in mid-fetal life, and bone marrow from the fifth month onward, restricted after puberty to the axial skeleton.
Which stage of red cell maturation does erythropoietin chiefly act on?
The colony-forming unit erythroid (CFU-E) stage, which it rescues from programmed cell death and drives into proerythroblasts.
Why is the reticulocyte count called the marrow response index?
It counts the youngest cells released, so it rises within a day or two when production accelerates and stays low when the marrow is aplastic or starved of nutrients.
How much bilirubin is produced from 1 g of haemoglobin breakdown?
About 35 mg of unconjugated bilirubin, released when splenic macrophages strip haem from effete red cells.